Table VII.
Most utilized outcome scores across continents
| Outcome score | North America | South America | Europe | Asia | Australia |
|---|---|---|---|---|---|
| NAHS | 42.0 ± 17.8 (6; 440; 7.2%) | 48.9 ± 4.96 (9; 422; 11.6%) | 67.1 ± 7.0 (2; 601; 89%) | ||
| HOS | |||||
| Activities of daily living | 70.0 ± 11.7 (8; 398; 6.5%) | 52.8 (1; 4; 0.1%) | |||
| Sports | 44.1 ± 6.34 (9; 463; 7.6%) | nr | |||
| Modified HHS | 61.6 ± 6.51 (23; 2519; 41%) | 56.1 (1; 7; 1.9%) | 58.2 ± 13.7 (7; 1006; 28%) | 46.1 (1; 40; 20%) | 68.0 ± 7.1 (2; 601; 89%) |
| HHS | 50.4 ± 13.2 (3; 47; 24%) | ||||
| Hip disability and Osteoarthritis Outcome Score | |||||
| Pain | 46.4 (1; 94; 2.6%) | ||||
| Symptoms | 44.2 (1; 94; 2.6%) | ||||
| Activities of daily living | 51.1 (1; 94; 2.6%) | ||||
| Sports and recreation | 30.7 (1; 94; 2.6%) | ||||
| Quality of life | 39.6 (1; 94; 2.6%) | ||||
| WOMAC | 36.6 ± 7.8 (3; 180; 2.9%) | 47.2 ± 20.4 (3; 172; 4.7% | 65 (1; 2; 1.0%) | ||
| Tegner activity score | 7.6 (1; 15; 0.4%) | ||||
| SF-12 | |||||
| PCS | 46.6 ± 18.0 (3; 1503; 25%) | ||||
| MCS | 53 (1; 1264; 21%) | ||||
| iHOT-12 | |||||
| iHOT-33 | |||||
| SF-36 | |||||
| EQ-5-QoL | |||||
| Marx activity score | |||||
nr, not recorded.
Blank cells indicate that no clinical outcome score was utilized. In parentheses: (number of studies reporting this variable; number of subjects with this variable measured; proportion of subjects within overall geographic area with that variable measured).